Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 134.06%123.35M | 93.64%94.82M | 1,169.72%411.47M | 167.43%174.62M | 104.54%44.8M | 110.64%52.7M | 110.20%48.97M | 758.39%32.41M | -31.49%65.3M | -31.20%21.9M |
| Net income from continuing operations | 133.04%49.27M | 98.69%48.21M | -499.38%-69.83M | 429.44%88.98M | 144.64%26.09M | 293.74%21.14M | 89.17%24.27M | 32.11%17.49M | -159.01%-27.01M | -412.69%-58.44M |
| Operating gains losses | 84.04%-331K | 242.57%2.17M | 381.56%2.57M | -1,051.85%-6.7M | -177.13%-2.2M | -44.33%-2.07M | -238.56%-1.52M | 49.47%-911K | -93.80%704K | 44.44%2.85M |
| Depreciation and amortization | 272.46%43.65M | 321.29%40.87M | 89.55%16.92M | 40.95%41.09M | 25.78%10.75M | 52.36%11.72M | 39.64%9.7M | 49.46%8.93M | 91.42%29.15M | 462.04%8.54M |
| Asset impairment expenditure | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --72.74M | ---- |
| Unrealized gains and losses of investment securities | --16.74M | --3M | --80.73M | ---3.14M | ---3.14M | --0 | --0 | --0 | --0 | ---- |
| Remuneration paid in stock | 51.97%1.08M | 89.34%1.58M | 133.83%3.32M | 49.49%4.82M | 183.59%1.85M | 8.54%712K | 3.60%835K | 28.18%1.42M | 31.63%3.22M | 23.95%652K |
| Deferred tax | -58.41%7.7M | 10.51%24.32M | ---- | 152.23%87.28M | 695.73%54.09M | 49.68%18.51M | 104.33%22.01M | ---- | 6.06%34.6M | 2.46%6.8M |
| Other non cashItems | -352.02%-4.99M | -719.13%-17.47M | 793,325.53%372.91M | -73.95%3.19M | 4.82%1.22M | -62.21%1.98M | -184.14%-2.13M | -98.58%47K | 79.71%12.24M | -59.66%1.16M |
| Change In working capital | 1,337.08%10.23M | -87.61%-7.86M | -4.30%10.24M | 150.01%1.8M | 59.17%-1.16M | -77.95%712K | -569.62%-4.19M | 319.43%10.7M | 77.19%-3.6M | -539.20%-2.85M |
| -Change in receivables | 110.79%357K | -2,031.89%-7.89M | -200.69%-4.11M | 284.45%1.6M | 169.33%1.2M | -794.32%-3.31M | -146.13%-370K | 577.43%4.08M | 89.27%-868K | 72.20%-1.73M |
| -Change in inventory | -897.09%-3.56M | -2,226.15%-3.02M | 929.26%6.82M | 75.24%-1.4M | -291.91%-2.38M | 141.89%447K | 91.59%-130K | 127.44%663K | 38.60%-5.64M | -138.26%-606K |
| -Change in payables and accrued expense | 275.99%13.44M | 182.76%3.05M | 26.40%7.52M | -45.11%1.59M | 102.93%15K | -23.40%3.57M | -325.49%-3.69M | 306.17%5.95M | 95.29%2.9M | -134.69%-512K |
| Interest received (cash flow from operating activities) | ---- | ---- | 227.66%6.8M | ---- | ---- | ---- | ---- | --2.08M | ---- | ---- |
| Tax refund paid | ---- | ---- | -66.08%-12.17M | 24.77%-42.7M | -32.61%-12.67M | -11.51%-9.03M | 81.41%-2.34M | 72.37%-7.33M | -1,701.84%-56.76M | -821.41%-9.56M |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 134.06%123.35M | 93.64%94.82M | 1,169.72%411.47M | 167.43%174.62M | 104.54%44.8M | 110.64%52.7M | 110.20%48.97M | 758.39%32.41M | -31.49%65.3M | -31.20%21.9M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -309.26%-30.23M | -524.38%-30.63M | -9,517.32%-815.55M | 47.43%-21.94M | 81.97%-5.42M | -18.57%-7.39M | -1.28%-4.91M | -1,332.43%-8.48M | -212.43%-41.73M | -48.91%-30.06M |
| Capital expenditure reported | ---- | -636.42%-22.85M | -78.84%-6.93M | -4.82%-13.32M | ---- | ---- | ---3.1M | ---3.88M | ---12.71M | ---- |
| Net PPE purchase and sale | -288.51%-30.6M | -218.34%-25.03M | -17,408.33%-809.24M | -97.69%-16.11M | 39.56%8.13M | -22.59%-7.88M | -63.83%-7.86M | -68.20%-4.62M | 54.67%-8.15M | 169.01%5.82M |
| Net business purchase and sale | --4.37M | --0 | ---- | ---2.67M | --0 | --0 | ---2.67M | ---- | --0 | --0 |
| Net other investing changes | -921.93%-4.01M | -199.68%-5.6M | 3,333.33%618K | 148.65%10.16M | 99.02%-228K | 151.55%488K | 12,593.33%5.62M | -99.17%18K | -456.94%-20.87M | -97.25%-23.18M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -309.26%-30.23M | -524.38%-30.63M | -9,517.32%-815.55M | 47.43%-21.94M | 81.97%-5.42M | -18.57%-7.39M | -1.28%-4.91M | -1,332.43%-8.48M | -212.43%-41.73M | -48.91%-30.06M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 200.66%19.2M | -343.06%-33.76M | 22,055.78%427.48M | -274.23%-86.56M | -108.18%-57.93M | -13,143.75%-19.07M | -164.16%-7.62M | 72.34%-1.95M | -330.02%-23.13M | -500.30%-27.82M |
| Net issuance payments of debt | 95.54%-901K | -196.91%-30.41M | 187,511.67%449.79M | -139.02%-89.7M | -129.58%-59.03M | -6,982.81%-20.19M | -76.06%-10.24M | 95.80%-240K | -129.87%-37.53M | -345.94%-25.71M |
| Net common stock issuance | ---- | ---- | ---- | --0 | --0 | --0 | --0 | ---- | 7,162.84%18.43M | --0 |
| Cash dividends paid | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Proceeds from stock option exercised by employees | 932.69%26.76M | -20.35%3.52M | -10,740.12%-18.3M | 16.30%9.03M | 211.66%1.85M | 13.49%2.59M | 130.41%4.42M | -94.20%172K | -61.25%7.76M | -83.10%592K |
| Interest paid (cash flow from financing activities) | -351.22%-6.66M | -282.71%-6.86M | -50.19%-2.82M | 50.11%-5.89M | 72.70%-738K | 31.09%-1.48M | 32.54%-1.79M | 56.24%-1.88M | -33.81%-11.8M | -17.17%-2.7M |
| Net other financing activities | ---- | ---- | ---1.19M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 200.66%19.2M | -343.06%-33.76M | 22,055.78%427.48M | -274.23%-86.56M | -108.18%-57.93M | -13,143.75%-19.07M | -164.16%-7.62M | 72.34%-1.95M | -330.02%-23.13M | -500.30%-27.82M |
| Net cash flow | ||||||||||
| Beginning cash position | 39.63%215.45M | 56.04%184.23M | 66.46%160.85M | 0.37%96.63M | 36.26%180.9M | 34.73%154.3M | 40.88%118.07M | 0.37%96.63M | 369.28%96.28M | 48.92%132.76M |
| Current changes in cash | 328.00%112.31M | -16.49%30.43M | 6.44%23.4M | 15,030.21%66.12M | 48.46%-18.55M | 40.74%26.24M | 20.17%36.44M | 275.10%21.98M | -99.43%437K | -613.09%-35.98M |
| Effect of exchange rate changes | -336.62%-840K | 475.12%784K | 97.61%-13K | -2,191.57%-1.9M | -959.15%-1.5M | 184.93%355K | -153.05%-209K | -755.42%-544K | 89.80%-83K | -221.37%-142K |
| End cash Position | 80.72%326.92M | 39.63%215.45M | 56.04%184.23M | 66.46%160.85M | 66.46%160.85M | 36.26%180.9M | 34.73%154.3M | 40.88%118.07M | 0.37%96.63M | 0.37%96.63M |
| Free cash from | 106.93%92.75M | 68.59%69.3M | -1,792.75%-404.7M | 226.70%145.19M | 163.70%39.61M | 141.05%44.82M | 122.24%41.11M | 411.71%23.91M | -42.53%44.44M | -35.81%15.02M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.